rivervest.com
Active Portfolio - RiverVest Venture Partners
http://www.rivervest.com/portfolio
Investing in Life Science Innovation. Has funded 34 and exited or taken public 20 innovative life science companies. Focusing primarily on the medical device and biopharmaceutical industries, RiverVest currently has assets under management of more than $290 million. Allakos, Inc., San Carlos, CA. Amplyx Pharmaceuticals, Inc., LaJolla, CA. InterVene, Inc., Mountain View, CA. Lyric Pharmaceuticals, Inc., San Francisco, CA. Neuros Medical, Inc., Willoughby, OH. Otonomy, Inc., San Diego, CA.
fogartyinstituteforinnovation.com
Portfolio - Fogarty Institute for Innovation
http://www.fogartyinstituteforinnovation.com/innovation-portfolio.php
Women and Infant Healthcare. Diagnostics and cardiac healthcare. Since beginning operations in late 2007, The Fogarty Institute for Innovation has provided support to more than 10 innovative entrepreneurs in our "Innovation: Cultivation" program. HeartFlow. Niveus and PQ Bypass have moved on to establish independent offices. Our other innovators in residence are in various stages of development, but all are moving toward independence with astounding speed and efficiency. Once applied the technology will ...
fogartyinstituteforinnovation.com
News and Events - Fogarty Institute for Innovation
http://www.fogartyinstituteforinnovation.com/news-20150722.php
Women and Infant Healthcare. Diagnostics and cardiac healthcare. Johnston Communications for Fogarty Institute for Innovation. Fogarty Institute for Innovation Strengthens Presence in Women's Healthcare Innovation, Adding Three New Startups. New early stage companies targeting unmet women's healthcare needs join the Institute as two successful startups graduate -. Marz Medical and Madorra. Have joined the organization as new companies-in-residence. Both these companies recently raised Series A funding, u...
fogartyinstituteforinnovation.org
Clinical Research: Validation - Fogarty Institute for Innovation
http://www.fogartyinstituteforinnovation.org/graduates.php
Women and Infant Healthcare. Diagnostics and cardiac healthcare. At the Fogarty Institute for Innovation, we judge the success of our companies on four key components: the quality of the company, funding attainment, the number of patients that will potentially be treated and if the startup/innovator will have a long-term impact on healthcare. We are proud that our graduates have met all these standards prior to leaving the Institute. Developed the first percutaneous approach to bypass the femoral artery ...
fogartyinstitute.com
Clinical Research: Validation - Fogarty Institute for Innovation
http://www.fogartyinstitute.com/graduates.php
Women and Infant Healthcare. Diagnostics and cardiac healthcare. At the Fogarty Institute for Innovation, we judge the success of our companies on four key components: the quality of the company, funding attainment, the number of patients that will potentially be treated and if the startup/innovator will have a long-term impact on healthcare. We are proud that our graduates have met all these standards prior to leaving the Institute. Developed the first percutaneous approach to bypass the femoral artery ...
fogartyinstitute.com
News and Events - Fogarty Institute for Innovation
http://www.fogartyinstitute.com/news-20150722.php
Women and Infant Healthcare. Diagnostics and cardiac healthcare. Johnston Communications for Fogarty Institute for Innovation. Fogarty Institute for Innovation Strengthens Presence in Women's Healthcare Innovation, Adding Three New Startups. New early stage companies targeting unmet women's healthcare needs join the Institute as two successful startups graduate -. Marz Medical and Madorra. Have joined the organization as new companies-in-residence. Both these companies recently raised Series A funding, u...
fogartyinstituteforinnovation.com
Clinical Research: Validation - Fogarty Institute for Innovation
http://www.fogartyinstituteforinnovation.com/graduates.php
Women and Infant Healthcare. Diagnostics and cardiac healthcare. At the Fogarty Institute for Innovation, we judge the success of our companies on four key components: the quality of the company, funding attainment, the number of patients that will potentially be treated and if the startup/innovator will have a long-term impact on healthcare. We are proud that our graduates have met all these standards prior to leaving the Institute. Developed the first percutaneous approach to bypass the femoral artery ...
fogartyinstitute.com
Portfolio - Fogarty Institute for Innovation
http://www.fogartyinstitute.com/innovation-portfolio.php
Women and Infant Healthcare. Diagnostics and cardiac healthcare. Since beginning operations in late 2007, The Fogarty Institute for Innovation has provided support to more than 10 innovative entrepreneurs in our "Innovation: Cultivation" program. HeartFlow. Niveus and PQ Bypass have moved on to establish independent offices. Our other innovators in residence are in various stages of development, but all are moving toward independence with astounding speed and efficiency. Once applied the technology will ...
fogartyinstitute.net
News and Events - Fogarty Institute for Innovation
http://www.fogartyinstitute.net/news-20150722.php
Women and Infant Healthcare. Diagnostics and cardiac healthcare. Johnston Communications for Fogarty Institute for Innovation. Fogarty Institute for Innovation Strengthens Presence in Women's Healthcare Innovation, Adding Three New Startups. New early stage companies targeting unmet women's healthcare needs join the Institute as two successful startups graduate -. Marz Medical and Madorra. Have joined the organization as new companies-in-residence. Both these companies recently raised Series A funding, u...
fogartyinstituteforinnovation.org
Portfolio - Fogarty Institute for Innovation
http://www.fogartyinstituteforinnovation.org/innovation-portfolio.php
Women and Infant Healthcare. Diagnostics and cardiac healthcare. Since beginning operations in late 2007, The Fogarty Institute for Innovation has provided support to more than 10 innovative entrepreneurs in our "Innovation: Cultivation" program. HeartFlow. Niveus and PQ Bypass have moved on to establish independent offices. Our other innovators in residence are in various stages of development, but all are moving toward independence with astounding speed and efficiency. Once applied the technology will ...